12-49838555-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_181708.3(BCDIN3D):āc.695A>Gā(p.Asn232Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000315 in 1,614,162 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_181708.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BCDIN3D | NM_181708.3 | c.695A>G | p.Asn232Ser | missense_variant | 2/2 | ENST00000333924.6 | NP_859059.1 | |
BCDIN3D-AS1 | NR_027499.1 | n.489T>C | non_coding_transcript_exon_variant | 3/3 | ||||
BCDIN3D-AS1 | NR_027500.1 | n.485T>C | non_coding_transcript_exon_variant | 3/4 | ||||
BCDIN3D-AS1 | NR_027501.1 | n.485T>C | non_coding_transcript_exon_variant | 3/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BCDIN3D | ENST00000333924.6 | c.695A>G | p.Asn232Ser | missense_variant | 2/2 | 1 | NM_181708.3 | ENSP00000335201.4 |
Frequencies
GnomAD3 genomes AF: 0.000237 AC: 36AN: 152154Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000261 AC: 65AN: 249018Hom.: 0 AF XY: 0.000267 AC XY: 36AN XY: 134804
GnomAD4 exome AF: 0.000324 AC: 473AN: 1461890Hom.: 1 Cov.: 31 AF XY: 0.000336 AC XY: 244AN XY: 727244
GnomAD4 genome AF: 0.000236 AC: 36AN: 152272Hom.: 0 Cov.: 32 AF XY: 0.000269 AC XY: 20AN XY: 74470
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 18, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at